[Evaluation of a combined application of radiotherapy, carboquone, and PSK in malignant tumor--clinical results at 7 facilities].
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use*; D001487:Basidiomycota; D002225:Carbazilquinone / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011509:Proteoglycans / Q000008:administration & dosage / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D001389:Azirines; D011509:Proteoglycans; D002225:Carbazilquinone; C010770:polysaccharide-K